(MENAFN- GetNews)
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is transforming how companies approach this challenge with the introduction of the INBS Drug Reader, a groundbreaking tool designed to enhance workplace safety and accountability. Workplace safety is a top priority for industries where even a minor lapse in judgment or concentration can have serious consequences. In sectors such as manufacturing, construction, and logistics, ensuring that employees are fit for duty is essential. However, traditional drug testing methods often fall short, leading to delays in decision-making and potential risks to safety.
This Just In:
Intelligent Bio Solutions Surpasses 1,000 Installations of Drug Screening Readers, Marking 65% Growth in One Year
NEW YORK, Aug. 21, 2024 - Intelligent Bio Solutions Inc. (NASDAQ: $INBS), a leader in non-invasive drug testing, announced the installation of over 1,000 Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024. In the fiscal year ending June 2024, the company sold 407 readers, up 26% from the previous year, bringing the total installed readers to 1,037-a 65% increase from 630 in June 2023.
Read more.
The Limitations of Traditional Drug Testing
Traditional drug testing methods, including urine, saliva, and hair tests, have long been the standard in workplace safety protocols. However, these methods come with significant drawbacks. Urine tests, for example, can take 24 to 72 hours to deliver results, leaving employers in a state of uncertainty when rapid decisions are crucial. Saliva tests, while quicker, may not effectively detect long-term substance use. Hair testing, although it provides an extended detection window, can take up to 10 days to produce results, causing further delays in addressing potential safety risks.
These inefficiencies can lead to a reactive approach to workplace safety, where issues are addressed only after they have already caused harm. In industries like manufacturing, where heavy machinery is operated in close quarters, or in construction, where workers face hazardous environments daily, this delay can be costly and dangerous.
The INBS Drug Reader: A New Era of Workplace Safety
The INBS Drug Reader addresses these challenges head-on by providing a rapid, non-invasive solution for drug testing. Utilizing advanced biometric techniques, the device analyzes fingerprint sweat to detect drug use within a 16 to 24-hour window. The most significant advantage of the INBS Drug Reader is its ability to deliver results in just 10 minutes. This rapid turnaround time allows employers to make informed decisions quickly, preventing potential accidents and maintaining a safe work environment.
The device's portability and tamper-proof design make it ideal for on-site testing and random drug testing policies. Unlike traditional methods that often require off-site sample analysis and third-party involvement, the INBS Drug Reader can be easily deployed on location, ensuring that testing is both efficient and reliable.
Impact Across Critical Sectors
The transformative impact of the INBS Drug Reader is particularly evident in high-risk industries where safety and productivity are closely linked. In manufacturing, where precision and focus are critical, the ability to test employees on the spot ensures that only those who are truly fit to work are allowed on the production floor, reducing the risk of accidents and machinery-related injuries.
In the construction industry, where the stakes are even higher, ensuring that all workers are drug-free is essential for preventing workplace injuries and fatalities. The INBS Drug Reader's rapid testing capabilities help construction companies maintain stringent safety standards, protecting both workers and the integrity of their projects.
The logistics sector, particularly trucking and transportation, also stands to benefit significantly from the INBS Drug Reader. With the ability to conduct on-the-spot testing, companies can ensure that drivers are not under the influence while operating vehicles, thereby reducing the risk of road accidents and improving overall safety on the roads.
A Commitment to Safety and Accountability
Intelligent Bio Solutions Inc. is at the forefront of workplace safety innovation with the INBS Drug Reader. By addressing the limitations of traditional drug testing methods and providing a solution that meets the immediate needs of employers, INBS is setting a new standard in drug testing technology.
"The INBS Drug Reader not only enhances workplace safety by providing rapid and reliable results but also empowers employers to act swiftly, preventing accidents before they happen," said [Name, Title] of Intelligent Bio Solutions. "Our commitment to safety and accountability is reflected in this technology, which we believe will have a lasting impact across various industries."
As organizations continue to prioritize employee well-being and operational safety, the INBS Drug Reader stands out as a critical tool in the fight against workplace drug use. With its ability to deliver immediate results, enhance safety protocols, and support a culture of accountability, this innovative device is poised to revolutionize workplace safety in critical sectors.
For more information about the INBS Drug Reader and how it can help your organization maintain a safe workplace, please visit
.
Here are three additional companies under $2 demonstrating robust market trends, volume, and awareness:
Smart for Life, Inc. (NASDAQ: SMFL):
A wellness company focused on producing and distributing health and nutritional products, leveraging e-commerce and technology to expand its market reach.
Anew Medical, Inc. (NASDAQ: WENA):
A healthcare company specializing in medical devices and health tech solutions, driving innovation in patient care and diagnostics.
WW International, Inc. (NASDAQ: WW):
A global leader in weight management programs, incorporating digital platforms and AI-driven tools to enhance customer engagement.
These companies are actively leveraging technology in their respective sectors, showcasing market strength through their innovative products and services.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
MENAFN21082024003238003268ID1108587322